Common Stock, Shares, Outstanding of X4 Pharmaceuticals, Inc from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
X4 Pharmaceuticals, Inc quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • X4 Pharmaceuticals, Inc Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 25,146,411, a 85% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

X4 Pharmaceuticals, Inc Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 25,146,411 -143,364,853 -85% 30 Sep 2025 10-Q 05 Nov 2025 2025 Q3
Q2 2025 7,959,947 -160,236,233 -95% 30 Jun 2025 10-Q 08 Aug 2025 2025 Q2
Q1 2025 5,788,745 -162,149,036 -97% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 5,698,231 -161,736,364 -97% 31 Dec 2024 10-Q 05 Nov 2025 2025 Q3
Q3 2024 168,511,264 +3,805,552 +2.3% 30 Sep 2024 10-Q 13 Nov 2024 2024 Q3
Q2 2024 168,196,180 +3,778,169 +2.3% 30 Jun 2024 10-Q 08 Aug 2024 2024 Q2
Q1 2024 167,937,781 +45,730,293 +37% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 167,434,595 +45,767,345 +38% 31 Dec 2023 10-K 26 Mar 2025 2024 FY
Q3 2023 164,705,712 +95,971,159 +140% 30 Sep 2023 10-Q 09 Nov 2023 2023 Q3
Q2 2023 164,418,011 +133,426,813 +431% 30 Jun 2023 10-Q 10 Aug 2023 2023 Q3
Q1 2023 122,207,488 +91,398,012 +297% 31 Mar 2023 10-Q 04 May 2023 2022 Q3
Q4 2022 121,667,250 +93,539,593 +333% 31 Dec 2022 10-K 21 Mar 2024 2023 FY
Q3 2022 68,734,553 +44,025,826 +178% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 30,991,198 +6,406,340 +26% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 30,809,476 +7,383,047 +32% 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 28,127,657 +11,821,926 +73% 31 Dec 2021 10-K 21 Mar 2023 2022 FY
Q3 2021 24,708,727 +8,422,082 +52% 30 Sep 2021 10-Q 04 Nov 2021 2021 Q3
Q2 2021 24,584,858 30 Jun 2021 10-Q 03 Aug 2021 2021 Q2
Q1 2021 23,426,429 +7,284,561 +45% 31 Mar 2021 10-Q 06 May 2021 2021 Q1
Q4 2020 16,305,731 +176,869 +1.1% 31 Dec 2020 10-K 17 Mar 2022 2021 FY
Q3 2020 16,286,645 +3,850,440 +31% 30 Sep 2020 10-Q 05 Nov 2020 2020 Q3
Q1 2020 16,141,868 +9,417,357 +140% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 16,128,862 +15,777,210 +4487% 31 Dec 2019 10-K 19 Mar 2021 2020 FY
Q3 2019 12,436,205 -1,879,205 -13% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 12,429,057 -1,886,353 -13% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 6,724,511 -7,569,910 -53% 31 Mar 2019 10-Q 15 May 2019 2019 Q1
Q4 2018 351,652 -13,942,731 -98% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 14,315,410 30 Sep 2018 10-Q 09 Nov 2018 2018 Q3
Q2 2018 14,315,410 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 14,294,421 31 Mar 2018 10-Q 10 May 2018 2018 Q1
Q4 2017 14,294,383 31 Dec 2017 10-K 11 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.